Practice Apoptosis: When Partners Retire

Article

Kicking off the first in a series of podcasts, a noted healthcare consultant discusses how retirement can fracture a practice.

In today’s challenging environment, community oncology practices must devise new business models if they are to continue providing high quality care for patients while adequately compensating their physicians. Practices must also adapt to an environment in which professional-fee revenue plays an increasingly important role in reimbursing for care.

In short, busy community doctors need to create a sound business plan that complements the skills and needs of their partners. Building the right practice “chemistry” is tantamount to success. So, what happens when a partner, or two, decides to retire? In this podcast, noted healthcare consultant, Thomas A. Paivanas, discusses the realities, with the caveat, fortune favors a prepared mind.

Stay tuned for our next expert podcast: Martin Neltner talks about quality in cancer care, what it means to the busy practitioner as we move forward into our brave new world of healthcare…
 

           
 

Practice Apoptosis: When Partners Retire
Right mouse click and "Save As" to download

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content